Danaher Corporation (FRA:DAP)
Market Cap | 134.45B |
Revenue (ttm) | 20.75B |
Net Income (ttm) | 3.00B |
Shares Out | n/a |
EPS (ttm) | 4.16 |
PE Ratio | 44.88 |
Forward PE | 26.81 |
Dividend | 1.10 (0.57%) |
Ex-Dividend Date | Sep 26, 2025 |
Volume | 4,661 |
Average Volume | 524 |
Open | 178.58 |
Previous Close | 180.72 |
Day's Range | 174.20 - 197.34 |
52-Week Range | 150.14 - 257.75 |
Beta | n/a |
RSI | 69.31 |
Earnings Date | Oct 21, 2025 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript
Danaher Corporation (NYSE:DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT Company Participants John Bedford - Vice President of Investor Relations Rainer Blair - President, CEO & Director Mat...
Danaher (DHR) Surges After Beating Q3 2025 Estimates, Reaffirms Outlook
Danaher (DHR) Surges After Beating Q3 2025 Estimates, Reaffirms Outlook
Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Stre...

Danaher rises as Diagnostics unit powers Q3 beat
Danaher (DHR) stock rises as the company beats Street forecasts with its Q3 2025 financials thanks mainly to its Diagnostics division. Read more here.
Danaher Corporation 2025 Q3 - Results - Earnings Call Presentation
Danaher Q3 Results Top Market, Confirms FY25 Outlook - Update
(RTTNews) - Science and technology company Danaher Corp. (DHR), while reporting higher third-quarter results above market estimates, on Tuesday maintained its fiscal 2025 outlook.
Danaher (DHR) Posts Strong Q3 Results, Beats Expectations
Danaher (DHR) Posts Strong Q3 Results, Beats Expectations
Danaher Corp Surpasses Q3 Expectations with EPS of $1.27 and Revenue of $6.1 Billion
Danaher Corp Surpasses Q3 Expectations with EPS of $1.27 and Revenue of $6.1 Billion
Danaher (DHR) Maintains Revenue and Earnings Guidance for 2025
Danaher (DHR) Maintains Revenue and Earnings Guidance for 2025
DHR Exceeds Q3 Revenue Expectations with Robust Performance
DHR Exceeds Q3 Revenue Expectations with Robust Performance
Danaher (DHR) Q3 Earnings and Revenues Beat Estimates
Danaher (DHR) delivered earnings and revenue surprises of +10.53% and +0.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Danaher beats quarterly estimates on strength in diagnostic tools and tech
Life Sciences firm Danaher on Tuesday beat Wall Street's third-quarter profit and revenue estimates, buoyed by resilient demand for its diagnostic testing tools and services, sending its shares up 1.3...
Danaher Q3 25 Earnings Conference Call At 8:00 AM ET
(RTTNews) - Danaher Corp. (DHR) will host a conference call at 8:00 AM ET on October 21, 2025, to discuss Q3 25 earnings results.

Danaher Sales and Profit Rise on Bioprocessing Momentum
Danaher recorded higher third-quarter sales and profit on the back of momentum in its bioprocessing business and better-than-expected sales in its respiratory market.
Danaher Corp. Q3 Profit Increases, Beats Estimates
(RTTNews) - Danaher Corp. (DHR) reported a profit for its third quarter that Increased from last year and beat the Street estimates.
Danaher beats top-line and bottom-line estimates; reaffirms FY25 outlook
Danaher press release (DHR): Q3 Non-GAAP EPS of $1.89 beats by $0.17. Revenue of $6.05B (+4.3% Y/Y) beats by $50M. Non-GAAP core revenue increased 3.0% year-over-year.

Danaher Reports Third Quarter 2025 Results
WASHINGTON , Oct. 21, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 26, 2025. Key Third Quarter 2025 Results Net earnings...

Earnings Scheduled For October 21, 2025
Companies Reporting Before The Bell • Valmont Industries (NYSE: VMI) is estimated to report quarterly earnings at $4.63 per share on revenue of $1.04 billion. • General Motors (NYSE: GM) is projecte...

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher ...
Danaher (DHR) Prepares for Q3 Earnings Release with Mixed Expectations
Danaher (DHR) Prepares for Q3 Earnings Release with Mixed Expectations
Pre-Market Earnings Report for October 21, 2025 : GE, KO, PM, RTX, DHR, LMT, NOC, MMM, ELV, GM, NDAQ, PCAR
The following companies are expected to report earnings prior to market open on 10/21/2025. Visit our Earnings Calendar for a full list of expected earnings releases.GE Aerospace (GE)is reporting for ...
Danaher Q3 2025 Earnings Preview
LH vs. DHR: Which Stock Is the Better Value Option?
LH vs. DHR: Which Stock Is the Better Value Option?

Examining the Future: Danaher's Earnings Outlook
Danaher (NYSE: DHR) is preparing to release its quarterly earnings on Tuesday, 2025-10-21. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Danah...
Validea Detailed Fundamental Analysis - DHR
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of Pim v...